Evidence map›Paper›PMID 38429642›Full record

ArticleBMC cancer2024

The novel circRNA circ_0045881 inhibits cell proliferation and invasion by targeting mir-214-3p in triple-negative breast cancer.

Jie Ren, Wei Chen, Ya Zhou, Jianxiong Sun, Guoqin Jiang

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Circular RNAs in ferroptosis regulation and tumor progression of gynecological and breast cancers: molecular mechanisms and therapeutic potential.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. circRNA-79530 regulates Twist-mediated mitochondrial damageEuropean journal of histochemistry : EJH · 2025
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jie Ren *Department of General Surgery, The Second Affiliated Hospital of Soochow University, No. 1055 Sanxiang Road, 215004, Suzhou, Jiangsu Province, China.
Wei Chen *Surgery Department, Suzhou Wuzhong People's Hospital, 215128, Suzhou, Jiangsu Province, China.
Ya ZhouDepartment of General Surgery, The Second Affiliated Hospital of Soochow University, No. 1055 Sanxiang Road, 215004, Suzhou, Jiangsu Province, China.
Jianxiong SunDepartment of General Surgery, The Second Affiliated Hospital of Soochow University, No. 1055 Sanxiang Road, 215004, Suzhou, Jiangsu Province, China.
Guoqin JiangDepartment of General Surgery, The Second Affiliated Hospital of Soochow University, No. 1055 Sanxiang Road, 215004, Suzhou, Jiangsu Province, China. jiang_guoqin@163.com.
Soochow University · CNThe Fifth People’s Hospital of Suzhou · CN

Funding

Preponderant Clinic Discipline Group Project of the Second Affiliated Hospital of Soochow University XKTJ-XK202009Youth Employee Pre-research Fund Project of the Second Affiliated Hospital of Soochow University SDFEYQN1806
6 · The paper itself

Abstract

backgroundTriple-negative breast cancer (TNBC) is the most lethal subtype of breast cancer (BC). The circRNA-miRNA‒mRNA axis is a promising biomarker for the early diagnosis and prognosis of BC. However, the critical circRNA mediators involved in TNBC progression and the underlying regulatory mechanism involved remain largely unclear.

methodsIn this study, we carried out a circRNA microarray analysis of 6 TNBC patients and performed a gene ontology (GO) analysis. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis was used to characterize important circRNAs involved in TNBC progression. The interaction between circRNAs and miRNAs was determined by dual luciferase and RNA immunoprecipitation (RIP) assays. Moreover, Transwell, wound healing and Cell Counting Kit-8 (CCK8) assays were performed with altered circRNA or miRNA expression in MDA-MB-231 and BT-549 cells to investigate the roles of these genes in cell invasion, migration and proliferation.

resultsA total of 78 circRNAs were differentially expressed in TNBC tissues, and the hsa_circ_0045881 level was significantly decreased in TNBC tissues and cells. Lentivirus-mediated hsa_circ_0045881 overexpression in MDA-MB-231 and BT-549 cells significantly reduced cell invasion and migration capacity. Additionally, hsa_circ_0045881 interacted with miR-214-3p in MDA-MB-231 cells. miR-214-3p mimics in MDA-MB-231 and BT-549 cells significantly enhanced cell invasion, migration and proliferation, but the other combinations of inhibitors had opposite effects on cell activity.

conclusionsOur data indicated that the circRNA has_circ_0045881 plays key roles in TNBC progression and that hsa_circ_0045881 might act as a sponge for miR-214-3p to modulate its levels in TNBC cells, thereby regulating cell invasion, metastasis and proliferation. hsa_circ_004588 might be a potential prognostic marker and therapeutic target for TNBC.

Indexed as

MicroRNAsTriple Negative Breast NeoplasmsBandagesCell Line, TumorCell ProliferationHumansRNA, CircularMicroRNAsMIRN214 microRNA, humanRNA, CircularcircRNAhsa_circ_0045881InvasionMigrationmiR-214-3pTriple-negative breast cancer

Identifiers

PMID38429642
PMCPMC10905830
OpenAlexW4392354528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.